Search

everythinglearnresearchcommunity

for

Search:↓

Higher DHT in male baldness may protect against prostate cancer.

Alopecia Areata is often linked to other health issues like allergies, thyroid problems, and diabetes.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Hair gets thinner, grayer, and changes texture with age due to genetics, environment, and cellular changes, affecting the growth cycle.

The woman's symptoms and tests suggest her adrenal glands are producing too many male hormones.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

Younger males with androgenic alopecia face significant psychological impacts but maintain better quality of life.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

Early hair loss in young males may not be clearly linked to insulin resistance or metabolic syndrome.

Ankle braces reduce motion, while external focus improves hip and knee movements.

Oral minoxidil may be a better treatment for hair loss than topical minoxidil.

Aging causes hair to gray and thin, with the timing of graying varying by race, and factors like oxidative stress and genetics can lead to hair loss.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Early diagnosis and treatment of endocrine disorders like HAIR-AN syndrome can improve outcomes in adolescents.

Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.

The conclusion is that proper communication about the realistic effects of hair loss and skin aging treatments can improve dermatologists' credibility.

EAAT4 decreases with age, harming skin function and calcium balance.

Hormone levels in women with androgenetic alopecia are similar to those without the condition.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.

Aging changes sugar molecules on skin stem cells, which may affect their ability to repair skin.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Men with androgenetic alopecia may have higher blood pressure, suggesting early screening for hypertension.